177 related articles for article (PubMed ID: 34507656)
1. Fertility preservation among young breast cancer patients: A single-center experience in China.
Wan Q; Han L; Liu J; Li H; Li Y; Long QM; Tan L; Li JJ
Taiwan J Obstet Gynecol; 2021 Sep; 60(5):827-830. PubMed ID: 34507656
[TBL] [Abstract][Full Text] [Related]
2. Random Start Ovarian Stimulation for Oocyte or Embryo Cryopreservation in Women Desiring Fertility Preservation Prior to Gonadotoxic Cancer Therapy.
Danis RB; Pereira N; Elias RT
Curr Pharm Biotechnol; 2017 Nov; 18(8):609-613. PubMed ID: 28786354
[TBL] [Abstract][Full Text] [Related]
3. Gonadotropin-releasing hormone agonist trigger increases the number of oocytes and embryos available for cryopreservation in cancer patients undergoing ovarian stimulation for fertility preservation.
Pereira N; Kelly AG; Stone LD; Witzke JD; Lekovich JP; Elias RT; Schattman GL; Rosenwaks Z
Fertil Steril; 2017 Sep; 108(3):532-538. PubMed ID: 28865552
[TBL] [Abstract][Full Text] [Related]
4. Hereditary breast cancer and fertility preservation outcomes.
Arab S; Tulandi T; Buckett W
J Assist Reprod Genet; 2022 May; 39(5):1163-1168. PubMed ID: 35403930
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of controlled ovarian stimulation using GnRH antagonist protocols for emergency fertility preservation in young women with breast cancer-a prospective nationwide Swedish multicenter study.
Marklund A; Eloranta S; Wikander I; Kitlinski ML; Lood M; Nedstrand E; Thurin-Kjellberg A; Zhang P; Bergh J; Rodriguez-Wallberg KA
Hum Reprod; 2020 Apr; 35(4):929-938. PubMed ID: 32313940
[TBL] [Abstract][Full Text] [Related]
6. Value of early referral to fertility preservation in young women with breast cancer.
Lee S; Ozkavukcu S; Heytens E; Moy F; Oktay K
J Clin Oncol; 2010 Nov; 28(31):4683-6. PubMed ID: 20876425
[TBL] [Abstract][Full Text] [Related]
7. Fertility preservation in female patients with hematological disorders.
Wu D; Shen H
BMC Pregnancy Childbirth; 2022 Jan; 22(1):61. PubMed ID: 35065646
[TBL] [Abstract][Full Text] [Related]
8. BRCA1/2 gene mutations do not affect the capacity of oocytes from breast cancer candidates for fertility preservation to mature in vitro.
Grynberg M; Dagher Hayeck B; Papanikolaou EG; Sifer C; Sermondade N; Sonigo C
Hum Reprod; 2019 Feb; 34(2):374-379. PubMed ID: 30561604
[TBL] [Abstract][Full Text] [Related]
9. Similar in vitro maturation rates of oocytes retrieved during the follicular or luteal phase offer flexible options for urgent fertility preservation in breast cancer patients.
Grynberg M; Poulain M; le Parco S; Sifer C; Fanchin R; Frydman N
Hum Reprod; 2016 Mar; 31(3):623-9. PubMed ID: 26759139
[TBL] [Abstract][Full Text] [Related]
10. Fertility preservation options in breast cancer patients.
Kasum M; von Wolff M; Franulić D; Čehić E; Klepac-Pulanić T; Orešković S; Juras J
Gynecol Endocrinol; 2015; 31(11):846-51. PubMed ID: 26370157
[TBL] [Abstract][Full Text] [Related]
11. In vitro maturation improves oocyte or embryo cryopreservation outcome in breast cancer patients undergoing ovarian stimulation for fertility preservation.
Oktay K; Buyuk E; Rodriguez-Wallberg KA; Sahin G
Reprod Biomed Online; 2010 May; 20(5):634-8. PubMed ID: 20219430
[TBL] [Abstract][Full Text] [Related]
12. Counseling young women with early breast cancer on fertility preservation.
Ter Welle-Butalid MEE; Vriens IJHI; Derhaag JGJ; Leter EME; de Die-Smulders CEC; Smidt MM; van Golde RJTR; Tjan-Heijnen VCGV
J Assist Reprod Genet; 2019 Dec; 36(12):2593-2604. PubMed ID: 31760547
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of Fertility Preservation for Female Cancer Patients in a Single Tertiary Center.
Kim JH; Alzahrani HS; Lee SR; Kim SH; Chae HD
Yonsei Med J; 2023 Aug; 64(8):497-504. PubMed ID: 37488701
[TBL] [Abstract][Full Text] [Related]
14. [Fertility preserving methods in women with breast cancer before gonadotoxic therapy].
Halászová N; Crha I; Huser M; Weinberger V; Žáková J; Ješeta M; Lousová E; Filipinská E; Ventruba P
Ceska Gynekol; 2017; 82(4):287-292. PubMed ID: 28925272
[TBL] [Abstract][Full Text] [Related]
15. Controlled ovarian hyperstimulation in breast cancer patients: Does oestrogen receptor status make a difference?
Sii S; Polyakov A; Rozen G; Agresta F; Stern K
Aust N Z J Obstet Gynaecol; 2023 Dec; 63(6):774-779. PubMed ID: 37317583
[TBL] [Abstract][Full Text] [Related]
16. Combining fertility preservation procedures to spread the eggs across different baskets: a feasibility study.
Delattre S; Segers I; Van Moer E; Drakopoulos P; Mateizel I; Enghels L; Tournaye H; De Vos M
Hum Reprod; 2020 Nov; 35(11):2524-2536. PubMed ID: 32951035
[TBL] [Abstract][Full Text] [Related]
17. Antral follicle responsiveness to FSH, assessed by the follicular output rate (FORT), is altered in Hodgkin's lymphoma when compared with breast cancer candidates for fertility preservation.
Sonigo C; Comtet M; Duros S; Sifer C; Sermondade N; Grynberg M
J Assist Reprod Genet; 2018 Jan; 35(1):91-97. PubMed ID: 28986734
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer grade and stage do not affect fertility preservation outcomes.
Wald K; Wang A; Abel MK; Morris J; Letourneau JM; Mok-Lin E; Cedars MI; Rosen MP
J Assist Reprod Genet; 2022 May; 39(5):1155-1161. PubMed ID: 35320444
[TBL] [Abstract][Full Text] [Related]
19. FERTILITY PRESERVATION IN YOUNG WOMEN WITH EARLY-STAGE BREAST CANCER.
Vuković P; Kasum M; Raguž J; Lonjak N; Bilić Knežević S; Orešković I; Beketić Orešković L; Čehić E
Acta Clin Croat; 2019 Mar; 58(1):147-156. PubMed ID: 31363337
[TBL] [Abstract][Full Text] [Related]
20. In vitro maturation of germinal vesicle oocytes recovered after premature luteinizing hormone surge: description of a novel approach to fertility preservation.
Oktay K; Demirtas E; Son WY; Lostritto K; Chian RC; Tan SL
Fertil Steril; 2008 Jan; 89(1):228.e19-22. PubMed ID: 17517403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
